{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-23-046872","form_type":"8-K","ticker":"DTIL","cik":"0001357874","company_name":"PRECISION BIOSCIENCES INC","filed_at":"2023-09-07T23:59:59+00:00","discovered_at":"2026-05-14T18:03:33.695103+00:00","generated_at":"2026-06-10T22:39:36.409045+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Precision BioSciences Controller resigns; CFO Kelly named principal accounting officer","bullets":["Shane Barton resigned as VP and Corporate Controller, effective Sept 15, 2023.","CFO Alex Kelly appointed as principal accounting officer effective Sept 15, 2023.","Senior Director Mei Burris to assume responsibilities previously held by Barton.","Mei Burris is a CPA with prior roles at Heat Biologics and Cempra Pharmaceuticals."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-23-046872","json":"https://secwatch.observer/filing/0000950170-23-046872.json","markdown":"https://secwatch.observer/filing/0000950170-23-046872.md","text":"https://secwatch.observer/filing/0000950170-23-046872.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1357874/000095017023046872/0000950170-23-046872-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1357874/000095017023046872/dtil-20230831.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T22:39:36.409045+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"6e5501282b","claim":"Shane Barton resigned as Vice President and Corporate Controller at PRECISION BIOSCIENCES INC.","evidence_excerpt":"On August 31, 2023, Shane Barton notified Precision BioSciences, Inc. (the “Company”) of his resignation as the Company’s Vice President and Corporate Controller, effective September 15, 2023","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017023046872/0000950170-23-046872-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Vice President and Corporate Controller"}],"fact_type":"executive_change"},{"claim_id":"b87c7b17bd","claim":"Alex Kelly changed role as Chief Financial Officer and Principal Accounting Officer at PRECISION BIOSCIENCES INC.","evidence_excerpt":"On September 6, 2023, the Company’s Board of Directors designated Alex Kelly, the Company’s Chief Financial Officer and principal financial officer, to also serve as the Company’s principal accounting officer effective upon Mr. Barton’s departure.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1357874/000095017023046872/0000950170-23-046872-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"designated"},{"label":"Role","value":"Chief Financial Officer and Principal Accounting Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}